Nakisa Serry
Direttore/Membro del Consiglio presso Celgene Europe Ltd.
Provenienza dei contatti di primo grado di Nakisa Serry
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The company is based in Middlesex, UK.
3
| Subsidiary | Biotechnology | 3 |
Celgene UK Holdings Ltd.
Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding company. The company is based in London, UK.
2
| Subsidiary | Financial Conglomerates | 2 |
Celgene UK Manufacturing Ltd.
Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding company. The company is based in London, UK.
2
| Subsidiary | Financial Conglomerates | 2 |
Celgene UK Manufacturing (II) Ltd.
Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding company. The company is based in London, UK.
2
| Subsidiary | Financial Conglomerates | 2 |
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland.
2
| Public Company | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nakisa Serry tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
SHIRE | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Proactiv Skin Health Ltd.
Proactiv Skin Health Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aqsens Health Oy
Aqsens Health Oy Medical/Nursing ServicesHealth Services Aqsens Health Oy is a Finnish health and biotechnology start-up that specializes in developing non-invasive screening tests for high-impact diseases. The private company is located in Finland. The Finnish company's current research focuses on developing a mobile screening platform for infectious diseases and a reliable prostate cancer screening test using their e-trf technology and novel phage-based biosensors. The company's non-invasive screening and diagnostics technology is based on the e-trf method and bacteriophage biosensors. | Medical/Nursing Services | Director/Board Member | |
FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Chairman | |
SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Biotechnology | Chief Executive Officer | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MI MING MART HOLDINGS LIMITED | Specialty Stores | Director/Board Member | |
University of Helsinki | College/University | Graduate Degree | |
SIG GROUP AG | Industrial Machinery | Director/Board Member | |
Wohnungsgenossenschaft Johannstadt eG
Wohnungsgenossenschaft Johannstadt eG Real Estate DevelopmentFinance Wohnungsgenossenschaft Johannstadt eG operates as an online platform for searching apartments. The private company is based in Dresden, Germany. The CEOs of the German company are Thomas J. W. Dittrich, Alrik Mutze. | Real Estate Development | Chief Executive Officer | |
Technorama-The Swiss Science Center
Technorama-The Swiss Science Center Other Consumer ServicesConsumer Services Technorama-The Swiss Science Center operates as a science museum. It offers an experimental field, which allow all visitors, irrespective of age and background, the opportunity to get to know natural phenomena in an informal, hands-on, self-directed way. The company was founded in 1947 and is headquartered in Winterthur, Switzerland. | Other Consumer Services | Director/Board Member | |
Helbling Management Consulting AG | Corporate Officer/Principal | ||
PwC Strategy& (Germany) GmbH
PwC Strategy& (Germany) GmbH Miscellaneous Commercial ServicesCommercial Services PwC Strategy& (Germany) GmbH provides global strategy consulting services. It specializes in business, customer, operations, organization, and technology strategy. The company was founded in March 2014 and is headquartered in Dusseldorf, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
Queen's University | College/University | Undergraduate Degree | |
Amgen International AG | Director of Finance/CFO | ||
Foley & Lardner LLP
Foley & Lardner LLP Miscellaneous Commercial ServicesCommercial Services Foley & Lardner LLP engages in the provision of legal services. Its practice areas include employee benefits and executive compensation, environmental, estates and trusts, finance, international tax and transfer pricing, private equity and venture capital, real estate, securities, commodities and exchange regulation, taxation, and transactions. The company was founded by Asahel Finch and William Pitt Lynde on September 8, 1842 and is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Corporate Secretary | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel | |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Junior Achievement of New Jersey, Inc. | Director/Board Member | ||
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Comptroller/Controller/Auditor | |
University of Toronto | College/University | Graduate Degree | |
Brown University | College/University | Undergraduate Degree | |
Yale Law School | College/University | Graduate Degree | |
CELGENE | Biotechnology | Comptroller/Controller/Auditor | |
JUNO THERAPEUTICS INC | Biotechnology | Treasurer | |
Hong Kong Science & Technology Parks Corp.
Hong Kong Science & Technology Parks Corp. Miscellaneous Commercial ServicesCommercial Services Hong Kong Science & Technology Parks Corp. provides research and development in fields of science and technology. It helps the science and technology companies under its care by offering them both state-of-the-art facilities as well as value-added services including research and development offices, infrastructure, market-led laboratories, and technical centres with professional support services. The company was founde din 2002 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Hong Kong | College/University | Doctorate Degree | |
The Hong Kong University of Science & Technology | College/University | Masters Business Admin | |
SWATCH GROUP | Other Consumer Specialties | Corporate Officer/Principal | |
SULZER LTD | Industrial Machinery | Chief Executive Officer | |
Technische Universität München | College/University | Graduate Degree | |
Swiss-American Chamber of Commerce
Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
EVOTEC SE | Pharmaceuticals: Major | Chairman | |
IKARIA, INC. | Biotechnology | Chief Executive Officer | |
Merck & Co., Inc. /Cherokee Chemical Manufacturing Plant/ | Chemicals: Major Diversified | Corporate Officer/Principal | |
PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 19 |
Svizzera | 10 |
Germania | 6 |
Hong Kong | 5 |
Finlandia | 4 |
Settori
Health Technology | 22 |
Consumer Services | 10 |
Commercial Services | 7 |
Producer Manufacturing | 3 |
Finance | 3 |
Posizioni
Director/Board Member | 36 |
Corporate Officer/Principal | 16 |
Chief Executive Officer | 13 |
Chairman | 12 |
Graduate Degree | 6 |
Contatti più connessi
- Borsa valori
- Insiders
- Nakisa Serry
- Connessioni Società